期刊文献+

B型钠利尿肽(BNP)与心功能衰竭的相关性研究 被引量:13

Study on the correlation between BNP and CHF
下载PDF
导出
摘要 目的探讨血浆中B型钠利尿肽(BNP)水平与心力衰竭的关系。方法选取左心室收缩功能衰竭患者100例(试验组),对照组100例,心功能正常。试验组依据美国NYHA标准分级:Ⅰ级患者16例,Ⅱ级患者24例,Ⅲ级患者48例,Ⅳ级患者12例。采用放射免疫法测定血浆BNP水平,心脏彩色多普勒超声诊断仪测量左室射血分数(LVEF);Swan-Ganz球囊漂浮导管检测肺动脉压(PAP)。结果试验组BNP水平明显高于对照组,差异统计学意义(P<0.05)。血浆BNP与LVEF呈负相关(P<0.05),与肺动脉压力(PAP)正相关(P<0.05)。结论左心室收缩功能衰竭时患者血浆BNP升高,与衰竭程度正相关;血浆BNP浓度与肺动脉压力(PAP)呈正相关、LVEF呈负相关,存在线性关系。 Objective To explore the correlation between plasma levels of brain natriuretic peptide (BNP) and chronic heart failure (CHF). Methods One hundred patients with left ventricular systolic function failure due to coronary atherosclerosis including 70 males and 30 females (age range: 32 -78yr) were enrolled as trial group,and the other 100 healthy subjects including 80 males and 20 females (age range: 34 -58yr) were enrolled as control group. The patients in trial group included 16 cases at grade I ,24 cases at grade ]] ,48 cases at grade m and 12 cases at grade IV according to the NYHA classification standard. The plasma levels of BNP were detected by radio immune assay,left ventricular ejection fraction was determined by Doppler echocardiography, and pulmonary artery pressure (PAP) was detected by Swan-Ganz catheter. Results The plasma levels of BNP in trial group were significantly higher than those in control group ( P 〈0.05 ). The plasma BNP was negatively correlated to LVEF ( P 〈0.05 ), however, which was positively related with PAP ( P 〈0.05 ). Conclusion The plasma levels of BNP in patients with left ventricular systolic function failure are increased, which are positively correlated to failure degree;plasma levels of BNP were positivekly related with PAP, however, which are negatively correlated to LVEF with a linear relationship.
作者 郝学军
出处 《河北医药》 CAS 2014年第14期2091-2093,共3页 Hebei Medical Journal
关键词 B型钠利尿肽 肺动脉压 左心室射血分数 心功能衰竭 brain natriuretic peptide pulmonary artery pressure left ventricular ejection fraction chronic heart failure
  • 相关文献

参考文献12

  • 1Richards AM, Mc Donald, Fitzpatrick MA, et al. Atrial natriuretic hor- mone has biological effects in man at physiological plasma concentra- tions. J Clin Endoerinol Metab, 1988,7 : 1134-1139.
  • 2Brunner-La Roeea HP, Kaye DM, Woods RL, et al. Effects of intra,zenous brain natfiuretic peptide on regional sympathy activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coil Cardio1,2001,37 : 1221-1227.
  • 3Sud T, Kangawa K, Minamino N, et al. Anewnatriuretlc peptide in porcine brain. Nature, 1988,332:78-80.
  • 4McCullough PA. B-type natrinrctic peptides:a diagnostic breakthrough in heart Failure. Minerva Cardioangio1,2003,51:121-129.
  • 5齐剂,张桂英,朱庆章.颅脑外伤性尿崩症[J].中国神经精神疾病杂志,1995,21(6):345-347. 被引量:27
  • 6Magga J, Vuoheenaho O, Tokola H, et al. B-type natriuretie peptide: a myocytspecific maker for characterizing load-induced alterations in cardi- ac gene expression. Am Med, 1998,30: 39-45.
  • 7Nakagawa O, Ogawa Y, hoh H, etal. Rapid transcriptional activation and early mRNA turnover of brain natriurelic peptide in cardiocyte hypertro-phy:evidence for brain natriuretic peptide as an "emergency" cardicac hormone against ventricular overload. J Clin Invest, 1995,96 : 1280-1287.
  • 8Maeda K, Tsutamota T, Wada A, et al. Plasma brain natrinre peptide as abiochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998, 135:825-832.
  • 9Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology,2000,93:19-25.
  • 10Takayoshi T, Atsuyuki W, Keiko M, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circulation, 1997,96 : 509 -516.

二级参考文献18

  • 1Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med,1999,340:448-454.
  • 2Alonso-Martinez JL,Llorente-Diez B,Echegaray-Agara M, et al. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail, 2002,49: 331-336.
  • 3Kitamura K, Kangawa K, kawamoto M, et al. Adrenomedullin:a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun, 1993,192: 553-560.
  • 4Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000,93:19-25.
  • 5Suzuki T,Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. Jpn Heart J,2000,41:205.
  • 6Field SJ. E2F-1 functions in mice to promote apopote apoptosis and suppress proliferation. Cell, 1996,85: 54.
  • 7Fedak PW, Svetlana M, Altamentova SM, et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am J Physiol Heart Cire Physiol, 2003,284: 626-634.
  • 8Beinhardt D , Sigusch HH, Hen BE, et al. Cardiac remodeling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart, 2002, 88:525-530.
  • 9Levine M, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J Med, 1990,323:236-241.
  • 10Torr-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction(SOLVD). J Am Coll Cardiol, 1996,27:1201-1206.

共引文献34

同被引文献111

  • 1中华医学会心血管病学分会.高血压左室肥厚伴左心衰竭诊断治疗指南[J].中华心血管病杂志,2010,35(12) :1076-1095.
  • 2葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.259~265.
  • 3李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:389
  • 4无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3686
  • 5Yancy CW. 2013 ACCF/AHA Guideline for the Management of Heart Failure [S]. American:the American College of Cardiology Foundation Board of Trustees and the American Heart Associa- tion Science Advisory and Coordinating Committee,2013.
  • 6Luis V, Esther S J, Antonio P, et al. Diagnostic value of N-terminal pro-brain natriuretic peptide in pleural .effusions of cardiac origin[J].Areh Bronconeumol. 2011.47(5), 246-251.
  • 7Sudoh T,Kangawa K,Minamino N,et al. A new natriuretic peptide in porcine brain[J]. Nature, 1988,332(6159):78-81.
  • 8Moshal KS,Tipparaju SM, Vacek TP, et al .Mitoehondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia[J]. Am J Physiol Heart Circ Physiol, 2008,295(2) : H890 - 897.
  • 9Sundstrom J,Sullivan L, Selhub J, et al .Relation of plasma ho- mocysteine to left ventricular structure and function: the Fram- ingham Heart Study[J] .Eur Heart, 2004,25(6), 523 - 530.
  • 10The Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis [J].JA- MA, 2002,288(16) : 2015 - 2022.

引证文献13

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部